Rockefeller Capital Management
TEVA icon

Rockefeller Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Rockefeller Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$423K Buy
14,043
+1,980
+16% +$63.7K ﹤0.01% 2075
2025
Q4 		$377K Buy
12,063
+3,906
+48% +$96.2K ﹤0.01% 2049
2025
Q3 		$165K Buy
+8,157
New +$143K ﹤0.01% 2331
2024
Q2 		– Sell
-22,246
Closed -$314K – 1731
2024
Q1 		$314K Buy
+22,246
New +$280K ﹤0.01% 1582
2023
Q1 		– Sell
-16,356
Closed -$148K – 3699
2022
Q4 		$148K Buy
16,356
+2,355
+17% +$20.5K ﹤0.01% 1816
2022
Q3 		$112K Sell
14,001
-12,751
-48% -$113K ﹤0.01% 1933
2022
Q2 		$200K Buy
26,752
+336
+1% +$2.93K ﹤0.01% 1635
2022
Q1 		$247K Hold
26,416
– – ﹤0.01% 1605
2021
Q4 		$211K Buy
26,416
+6,833
+35% +$61.7K ﹤0.01% 1625
2021
Q3 		$190K Buy
19,583
+7,385
+61% +$69.2K ﹤0.01% 1603
2021
Q2 		$120K Buy
12,198
+10,228
+519% +$108K ﹤0.01% 1712
2021
Q1 		$22K Hold
1,970
– – ﹤0.01% 2243
2020
Q4 		$18K Buy
1,970
+222
+13% +$2.13K ﹤0.01% 2056
2020
Q3 		$15K Sell
1,748
-347
-17% -$3.67K ﹤0.01% 1893
2020
Q2 		$26K Sell
2,095
-8,165
-80% -$92.3K ﹤0.01% 1594
2020
Q1 		$92K Buy
10,260
+250
+2% +$2.56K ﹤0.01% 1040
2019
Q4 		$98K Buy
10,010
+8,861
+771% +$79.1K ﹤0.01% 979
2019
Q3 		$8K Sell
1,149
-102
-8% -$781 ﹤0.01% 1500
2019
Q2 		$11K Sell
1,251
-434
-26% -$5.23K ﹤0.01% 1209
2019
Q1 		$27K Buy
1,685
+663
+65% +$11.7K ﹤0.01% 1128
2018
Q4 		$16K Sell
1,022
-400
-28% -$8.2K ﹤0.01% 651
2018
Q3 		$31K Hold
1,422
– – ﹤0.01% 473
2018
Q2 		$35K Hold
1,422
– – ﹤0.01% 477
2018
Q1 		$24K Buy
+1,422
New +$27.8K ﹤0.01% 462

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rockefeller Capital Management's TEVA Position: Q1 2026 in Review

Rockefeller Capital Management increased its Teva Pharmaceuticals (TEVA) stake by 16% in Q1 2026, buying an estimated $63.7K and bringing the position to 14,043 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

Rockefeller Capital Management first reported a position in TEVA in Q1 2018 and has held it in 24 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Rockefeller Capital Management held 14,043 shares of Teva Pharmaceuticals worth $423K as of Q1 2026.
  • Rockefeller Capital Management bought 1,980 Teva Pharmaceuticals shares in Q1 2026, an estimated $63.7K.
  • Teva Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2075 holding.
  • Rockefeller Capital Management first reported a position in Teva Pharmaceuticals in Q1 2018 and has held it in 24 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.